{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:42:45Z","timestamp":1747154565893,"version":"3.40.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajicjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ajic.2023.08.020","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:38:41Z","timestamp":1693355921000},"page":"305-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of the COVID-19 pandemic on gram-negative bacteria susceptibility patterns in respiratory samples of intensive care units in the Brussels Capital Region, 2010-2021"],"prefix":"10.1016","volume":"52","author":[{"given":"Marco","family":"Moretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique Y.","family":"Miendje Deyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"De Geyter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Wybo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Claus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-600X","authenticated-orcid":false,"given":"Joop","family":"Jonckheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0522-9686","authenticated-orcid":false,"given":"Philippe","family":"Clevenbergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7697-6849","authenticated-orcid":false,"given":"Nicolas","family":"Dauby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2023.08.020_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.ajic.2023.08.020_bib2","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1093\/cid\/ciz824","article-title":"Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria","volume":"69","author":"Nordmann","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.08.020_bib3","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S1473-3099(19)30403-7","article-title":"Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial","volume":"19","author":"Kollef","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2023.08.020_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","article-title":"Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial","volume":"21","author":"Wunderink","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ajic.2023.08.020_bib5","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/ofid\/ofy347","article-title":"Variations in the occurrence of resistance phenotypes and carbapenemase genes among enterobacteriaceae isolates in 20 years of the SENTRY antimicrobial surveillance program","volume":"6","author":"Castanheira","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"2 Suppl","key":"10.1016\/j.ajic.2023.08.020_bib6","doi-asserted-by":"crossref","first-page":"373S","DOI":"10.1378\/chest.119.2_suppl.373S","article-title":"Hospital-acquired pneumonia: risk factors, microbiology, and treatment","volume":"119","author":"Lynch","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ajic.2023.08.020_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCC.0000000000000755","article-title":"Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic ventilator-associated pneumonia: new definitions","volume":"26","author":"Cant\u00f3n","year":"2020","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ajic.2023.08.020_bib8","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/jac\/dkab300","article-title":"Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey","volume":"76","author":"Tomczyk","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2023.08.020_bib9","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3390\/jcm9092744","article-title":"Antimicrobial stewardship program, COVID-19, and infection control: spread of carbapenem-resistant Klebsiella pneumoniae colonization in ICU COVID-19 patients. What did not work?","volume":"9","author":"Tiri","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajic.2023.08.020_bib10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/antibiotics11060826","article-title":"Long-term impact of the COVID-19 pandemic on in-hospital antibiotic consumption and antibiotic resistance: a time series analysis (2015-2021)","volume":"11","author":"Meschiari","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.08.020_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajic.2023.08.020_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajic.2023.08.020_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jac\/dkr400","article-title":"Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum -lactamase production in clinical Enterobacteriaceae isolates","volume":"67","author":"Polsfuss","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2023.08.020_bib14","first-page":"423","article-title":"Effect of COVID-19 on bacterial resistance","volume":"11","author":"Tizkam","year":"2020","journal-title":"Sys Rev Pharm"},{"key":"10.1016\/j.ajic.2023.08.020_bib15","first-page":"338","article-title":"Increment antimicrobial resistance during the COVID-19 pandemic: results from the invifar network","volume":"28","author":"L\u00f3pez-J\u00e1come","year":"2022","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ajic.2023.08.020_bib16","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/antibiotics10080954","article-title":"Paradigm shift in antimicrobial resistance pattern of bacterial isolates during the COVID-19 pandemic","volume":"10","author":"Saini","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.08.020_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106324","article-title":"Increased antimicrobial resistance during the COVID-19 pandemic","volume":"57","author":"Lai","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2023.08.020_bib18","article-title":"Antimicrobial use and aetiology of bloodstream infections in critically ill patients during early stages of SARS-CoV-2 pandemic","volume":"4","author":"Torrecillas","year":"2022","journal-title":"Infect Prev Pract"},{"key":"10.1016\/j.ajic.2023.08.020_bib19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/jcm12031189","article-title":"Clinical distribution and drug resistance of Pseudomonas aeruginosa in Guangzhou, China from 2017 to 2021","volume":"12","author":"Lyu","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajic.2023.08.020_bib20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/life11100996","article-title":"COVID-19 and antimicrobial resistance: data from the Greek electronic system for the surveillance of antimicrobial resistance-WHONET-Greece (January 2018-March 2021)","volume":"11","author":"Polemis","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.ajic.2023.08.020_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jac\/dkm467","article-title":"Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection","volume":"61","author":"De Jongh","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2023.08.020_bib22","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s10096-015-2406-x","article-title":"Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit","volume":"34","author":"Habayeb 1","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2023.08.020_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11739-021-02790-0","article-title":"Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers","volume":"17","author":"Van Laethem","year":"2022","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ajic.2023.08.020_bib24","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jiph.2022.07.009","article-title":"Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey","volume":"15","author":"El-Sokkary","year":"2022","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ajic.2023.08.020_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323005813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323005813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T03:09:11Z","timestamp":1725332951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655323005813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0196655323005813"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2023.08.020","relation":{},"ISSN":["0196-6553"],"issn-type":[{"type":"print","value":"0196-6553"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of the COVID-19 pandemic on gram-negative bacteria susceptibility patterns in respiratory samples of intensive care units in the Brussels Capital Region, 2010-2021","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2023.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}